|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.17 USD | 0.00% |
|
-1.21% | -28.01% |
| Feb. 06 | Barrington Trims Price Target on SurModics to $70 From $71, Keeps Outperform Rating | MT |
| Feb. 01 | Needham Adjusts SurModics' Price Target to $47 From $44, Maintains Buy Rating | MT |
Surmodics, Inc. reported earnings results for the first quarter ended December 31, 2023. For the first quarter, the company reported revenue was USD 30.55 million compared to USD 24.93 million a year ago. Net loss was USD 0.786 million compared to USD 7.84 million a year ago.
Basic loss per share from continuing operations was USD 0.06 compared to USD 0.56 a year ago. Diluted loss per share from continuing operations was USD 0.06 compared to USD 0.56 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -28.01% | 373M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
SURMODICS, INC. 
